Table 4 Presentation of patients with primary sclerosing cholangitis, their liver function tests on the last visit to the hospital and their outcomes
From: Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study
Gender of PSC patient | Age at diagnosis(years) | Type of IBD | AST (U/L) | ALT (U/L) | ALP (U/L) | GGT (U/L) | TBL (mg/dL) | Duration PSC (years) | Outcome |
|---|---|---|---|---|---|---|---|---|---|
1.Male | 32 | CD | 31 | 49 | 53 | 30 | 1 | 14 | Slow progression |
2.Male | 48 | UC | 33 | 62 | 103 | 132 | 0.8 | 9 | Slow progression |
3.Female | 51 | CD | 133 | 190 | 716 | 171 | 3.7 | 9 | Before liver transplantation |
4.Male | 17 | CD | 14 | 19 | 50 | 33 | 0.7 | 1 | Slow progression |
5.Female | 55 | CD | 41 | 56 | 43 | 15 | 0.9 | 19 | Slow progression |
6.Male | 27 | CD | 18 | 15 | 61 | 21 | 0.9 | 5 | Slow progression |
7.Male | 68 | UC | 97 | 58 | 92 | 41 | 0.7 | 12 | Cirrhosis |